The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076170 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Qingfang Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical, Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Disease Progression, Immunotherapy, Integrins, Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Integrins are a group of heterodimers consisting of α and β subunits that mediate a variety of physiological activities of immune cells, including cell migration, adhesion, proliferation, survival, and immunotolerance. Multiple types of integrins act differently on the same immune cells, while the same integrin may exert various effects on different immune cells. In the development of cancer, integrins are involved in the regulation of cancer cell proliferation, invasion, migration, and angiogenesis; conversely, integrins promote immune cell aggregation to mediate the elimination of tumors. The important roles of integrins in cancer progression have provided valuable clues for the diagnosis and targeted treatment of cancer. Furthermore, many integrin inhibitors have been investigated in clinical trials to explore effective regimens and reduce side effects. Due to the complexity of the mechanism of integrin-mediated cancer progression, challenges remain in the research and development of cancer immunotherapies (CITs). This review enumerates the effects of integrins on four types of immune cells and the potential mechanisms involved in the progression of cancer, which will provide ideas for more optimal CIT in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medical, Nanchang University, Nanchang 330006, China.
- Queen Mary School, Medical Department, Nanchang University, Nanchang 330031, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Q., Zhang, S., Chen, J., & Xie, Z. (2023). The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076170
Vancouver
Zhang Q, Zhang S, Chen J, Xie Z. The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076170
BibTeX
@article{Zhang2023,
author = {Zhang, Qingfang and Zhang, Shuo and Chen, Jianrui and Xie, Zhenzhen},
title = {The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076170}
}
EUVIMED